Tryptase, a novel angiogenic factor stored in mast cell granules

Domenico Ribatti, Girolamo Ranieri

Research output: Contribution to journalArticlepeer-review


Human mast cells (MCs) are a rich reservoir of neutral proteases, packed in large amounts in their granules and comprising a high fraction of all cellular proteins. Among these proteases, tryptase is involved in angiogenesis after its release from activated MC granules, as it has been demonstrated in different in vitro and in vivo assays. Moreover, tryptase-positive MCs increase in number and vascularization increases in a linear fashion in different solid and hematological tumors. This complex interplay between MCs and tumor angiogenesis have led to consider the therapeutic use of angiogenesis inhibitors, which specifically target the angiogenic activity of tryptase, such as gabexate mesilate and nafamostat mesilate, two inhibitors of trypsin-like serine proteases.

Original languageEnglish
Pages (from-to)157-162
Number of pages6
JournalExperimental Cell Research
Issue number2
Publication statusPublished - Mar 15 2015


  • Angiogenesis
  • Anti-angiogenesis
  • Mast cell
  • Tryptase
  • Tumor growth

ASJC Scopus subject areas

  • Cell Biology
  • Medicine(all)


Dive into the research topics of 'Tryptase, a novel angiogenic factor stored in mast cell granules'. Together they form a unique fingerprint.

Cite this